US › Healthcare

Nyxoah (NYXH)

US · Healthcare · Medical Instruments & Supplies

$1.45-0.68%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$7.4M

Revenue YoY

+591.9%

Net profit

$-18.4M

Profit YoY

+17.7%

EPS

$-0.43

EPS estimate

$-0.63

Net margin

-250.2%

EPS came in at -0.43 against a street estimate of -0.63 — a beat of 31.6%.

Key statistics

Market cap

$140.1M

Forward P/E

0.0

P/B

3.41

Book value

$0.94

EPS (TTM)

$-2.45

52-week high

$8.59

52-week low

$1.26

50-day MA

$1.85

200-day MA

$3.66

Beta

0.96

Analyst view

Analysts rate Nyxoah a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $8.40.

Shareholding

Insiders

33.78%

Institutions

26.85%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Nyxoah — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.